Maia Biotechnology Stock Technical Analysis
| MAIA Stock | USD 2.29 0.10 4.18% |
As of the 30th of January, MAIA Biotechnology secures the Mean Deviation of 5.75, downside deviation of 6.8, and Market Risk Adjusted Performance of 2.88. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MAIA Biotechnology, as well as the relationship between them.
MAIA Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as MAIA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MAIAMAIA Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.MAIA Biotechnology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.14 | Strong Buy | 1 | Odds |
Most MAIA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MAIA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MAIA Biotechnology, talking to its executives and customers, or listening to MAIA conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. Expected growth trajectory for MAIA significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MAIA Biotechnology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
MAIA Biotechnology's market price often diverges from its book value, the accounting figure shown on MAIA's balance sheet. Smart investors calculate MAIA Biotechnology's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since MAIA Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that MAIA Biotechnology's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MAIA Biotechnology represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MAIA Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MAIA Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MAIA Biotechnology.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in MAIA Biotechnology on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding MAIA Biotechnology or generate 0.0% return on investment in MAIA Biotechnology over 90 days. MAIA Biotechnology is related to or competes with Elutia, Lantern Pharma, Bioatla, PolyPid, RenovoRx, Annovis Bio, and Veru. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commerciali... More
MAIA Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MAIA Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MAIA Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.8 | |||
| Information Ratio | 0.1319 | |||
| Maximum Drawdown | 35.91 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 12.6 |
MAIA Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MAIA Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MAIA Biotechnology's standard deviation. In reality, there are many statistical measures that can use MAIA Biotechnology historical prices to predict the future MAIA Biotechnology's volatility.| Risk Adjusted Performance | 0.1107 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.5107 | |||
| Sortino Ratio | 0.1456 | |||
| Treynor Ratio | 2.87 |
MAIA Biotechnology January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1107 | |||
| Market Risk Adjusted Performance | 2.88 | |||
| Mean Deviation | 5.75 | |||
| Semi Deviation | 6.26 | |||
| Downside Deviation | 6.8 | |||
| Coefficient Of Variation | 713.91 | |||
| Standard Deviation | 7.5 | |||
| Variance | 56.28 | |||
| Information Ratio | 0.1319 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.5107 | |||
| Sortino Ratio | 0.1456 | |||
| Treynor Ratio | 2.87 | |||
| Maximum Drawdown | 35.91 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 12.6 | |||
| Downside Variance | 46.21 | |||
| Semi Variance | 39.21 | |||
| Expected Short fall | (6.32) | |||
| Skewness | 0.5456 | |||
| Kurtosis | 1.32 |
MAIA Biotechnology Backtested Returns
MAIA Biotechnology is very risky given 3 months investment horizon. MAIA Biotechnology has Sharpe Ratio of 0.18, which conveys that the company had a 0.18 % return per unit of volatility over the last 3 months. We were able to collect and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.39% are justified by taking the suggested risk. Use MAIA Biotechnology Market Risk Adjusted Performance of 2.88, downside deviation of 6.8, and Mean Deviation of 5.75 to evaluate company specific risk that cannot be diversified away. MAIA Biotechnology holds a performance score of 14 on a scale of zero to a hundred. The firm secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MAIA Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding MAIA Biotechnology is expected to be smaller as well. Use MAIA Biotechnology treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to analyze future returns on MAIA Biotechnology.
Auto-correlation | 0.76 |
Good predictability
MAIA Biotechnology has good predictability. Overlapping area represents the amount of predictability between MAIA Biotechnology time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MAIA Biotechnology price movement. The serial correlation of 0.76 indicates that around 76.0% of current MAIA Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
MAIA Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
MAIA Biotechnology Technical Analysis
Indicator |
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of MAIA Biotechnology volatility developed by Welles Wilder.
About MAIA Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of MAIA Biotechnology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of MAIA Biotechnology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on MAIA Biotechnology price pattern first instead of the macroeconomic environment surrounding MAIA Biotechnology. By analyzing MAIA Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of MAIA Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to MAIA Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 1.53 | 2.65 | 3.05 | 3.27 | Net Debt To EBITDA | 0.36 | 0.41 | 0.47 | 0.65 |
MAIA Biotechnology January 30, 2026 Technical Indicators
Most technical analysis of MAIA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for MAIA from various momentum indicators to cycle indicators. When you analyze MAIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1107 | |||
| Market Risk Adjusted Performance | 2.88 | |||
| Mean Deviation | 5.75 | |||
| Semi Deviation | 6.26 | |||
| Downside Deviation | 6.8 | |||
| Coefficient Of Variation | 713.91 | |||
| Standard Deviation | 7.5 | |||
| Variance | 56.28 | |||
| Information Ratio | 0.1319 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.5107 | |||
| Sortino Ratio | 0.1456 | |||
| Treynor Ratio | 2.87 | |||
| Maximum Drawdown | 35.91 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 12.6 | |||
| Downside Variance | 46.21 | |||
| Semi Variance | 39.21 | |||
| Expected Short fall | (6.32) | |||
| Skewness | 0.5456 | |||
| Kurtosis | 1.32 |
MAIA Biotechnology January 30, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as MAIA stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 2.29 | ||
| Day Typical Price | 2.29 | ||
| Price Action Indicator | (0.05) |
Complementary Tools for MAIA Stock analysis
When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |